NL7115017A - - Google Patents
Info
- Publication number
- NL7115017A NL7115017A NL7115017A NL7115017A NL7115017A NL 7115017 A NL7115017 A NL 7115017A NL 7115017 A NL7115017 A NL 7115017A NL 7115017 A NL7115017 A NL 7115017A NL 7115017 A NL7115017 A NL 7115017A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT5466070 | 1970-11-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL7115017A true NL7115017A (cg-RX-API-DMAC10.html) | 1972-05-16 |
| NL155016B NL155016B (nl) | 1977-11-15 |
Family
ID=11287460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL717115017A NL155016B (nl) | 1970-11-12 | 1971-11-01 | Werkwijze voor het bereiden van 6-methyl-8-carbonzuur-10-alkoxyergolinederivaten door invoering van de 10-alkoxygroep in een verbinding die zo'n groep niet draagt. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US3814765A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS5344478B1 (cg-RX-API-DMAC10.html) |
| AT (1) | AT310953B (cg-RX-API-DMAC10.html) |
| AU (1) | AU466630B2 (cg-RX-API-DMAC10.html) |
| BE (1) | BE775145A (cg-RX-API-DMAC10.html) |
| CA (1) | CA926864A (cg-RX-API-DMAC10.html) |
| CH (1) | CH561721A5 (cg-RX-API-DMAC10.html) |
| CS (1) | CS165363B2 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2155578C3 (cg-RX-API-DMAC10.html) |
| DK (1) | DK140842B (cg-RX-API-DMAC10.html) |
| FR (1) | FR2114476A5 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1315439A (cg-RX-API-DMAC10.html) |
| HU (1) | HU164041B (cg-RX-API-DMAC10.html) |
| IE (1) | IE35794B1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL38096A (cg-RX-API-DMAC10.html) |
| NL (1) | NL155016B (cg-RX-API-DMAC10.html) |
| NO (1) | NO128533B (cg-RX-API-DMAC10.html) |
| SE (1) | SE385707B (cg-RX-API-DMAC10.html) |
| SU (1) | SU406355A3 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA717541B (cg-RX-API-DMAC10.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3929796A (en) * | 1974-08-02 | 1975-12-30 | Lilly Co Eli | Synthesis of penniclavine and elymoclavine |
| US4001242A (en) * | 1974-08-02 | 1977-01-04 | Eli Lilly And Company | D-6-methyl-8-formyl-10α-alkoxy-8-ergolene |
| US3923812A (en) * | 1974-08-02 | 1975-12-02 | Lilly Co Eli | Synthesis of elymoclavine |
| US4054567A (en) * | 1975-08-11 | 1977-10-18 | Eli Lilly And Company | 6-Methyl-8β-hydroxymethyl-8-γ-substituted-9-ergolene compounds |
| US4082753A (en) * | 1976-02-17 | 1978-04-04 | Eli Lilly And Company | Penniclavine acetonide |
| SG181896A1 (en) * | 2009-12-23 | 2012-07-30 | Map Pharmaceuticals Inc | Novel ergoline analogs |
| JP2014517076A (ja) | 2011-06-23 | 2014-07-17 | マップ・ファーマシューティカルズ・インコーポレイテッド | 新規のフルオロエルゴリン類似体 |
| SG11201403434YA (en) | 2011-12-19 | 2014-09-26 | Map Pharmaceuticals Inc | Novel iso-ergoline derivatives |
| US8946420B2 (en) | 2011-12-21 | 2015-02-03 | Map Pharmaceuticals, Inc. | Neuromodulatory compounds |
| US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
-
1971
- 1971-10-04 US US00186385A patent/US3814765A/en not_active Expired - Lifetime
- 1971-11-01 NL NL717115017A patent/NL155016B/xx unknown
- 1971-11-01 AU AU35198/71A patent/AU466630B2/en not_active Expired
- 1971-11-08 FR FR7139938A patent/FR2114476A5/fr not_active Expired
- 1971-11-08 IL IL38096A patent/IL38096A/en unknown
- 1971-11-08 IE IE1406/71A patent/IE35794B1/xx unknown
- 1971-11-08 NO NO04110/71*[A patent/NO128533B/no unknown
- 1971-11-08 GB GB5177271A patent/GB1315439A/en not_active Expired
- 1971-11-08 CS CS7815A patent/CS165363B2/cs unknown
- 1971-11-08 CA CA127063A patent/CA926864A/en not_active Expired
- 1971-11-09 DE DE2155578A patent/DE2155578C3/de not_active Expired
- 1971-11-09 SE SE7114282A patent/SE385707B/xx unknown
- 1971-11-09 DK DK547271AA patent/DK140842B/da unknown
- 1971-11-09 ZA ZA717541A patent/ZA717541B/xx unknown
- 1971-11-09 SU SU1711760A patent/SU406355A3/ru active
- 1971-11-09 JP JP8876871A patent/JPS5344478B1/ja active Pending
- 1971-11-10 AT AT971071A patent/AT310953B/de not_active IP Right Cessation
- 1971-11-10 BE BE775145A patent/BE775145A/xx unknown
- 1971-11-11 CH CH1641871A patent/CH561721A5/xx not_active IP Right Cessation
- 1971-11-11 HU HUFA898A patent/HU164041B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH561721A5 (cg-RX-API-DMAC10.html) | 1975-05-15 |
| DK140842C (cg-RX-API-DMAC10.html) | 1980-05-05 |
| SE385707B (sv) | 1976-07-19 |
| AU3519871A (en) | 1973-05-10 |
| DK140842B (da) | 1979-11-26 |
| CS165363B2 (cg-RX-API-DMAC10.html) | 1975-12-22 |
| NO128533B (cg-RX-API-DMAC10.html) | 1973-12-03 |
| ZA717541B (en) | 1972-08-30 |
| US3814765A (en) | 1974-06-04 |
| FR2114476A5 (cg-RX-API-DMAC10.html) | 1972-06-30 |
| SU406355A3 (cg-RX-API-DMAC10.html) | 1973-11-05 |
| DE2155578B2 (de) | 1978-05-03 |
| CA926864A (en) | 1973-05-22 |
| AT310953B (de) | 1973-10-25 |
| IE35794B1 (en) | 1976-05-26 |
| NL155016B (nl) | 1977-11-15 |
| BE775145A (fr) | 1972-05-10 |
| DE2155578A1 (de) | 1972-05-18 |
| IE35794L (en) | 1972-05-12 |
| HU164041B (cg-RX-API-DMAC10.html) | 1973-12-28 |
| DE2155578C3 (de) | 1979-01-04 |
| AU466630B2 (en) | 1975-11-06 |
| JPS5344478B1 (cg-RX-API-DMAC10.html) | 1978-11-29 |
| IL38096A (en) | 1976-02-29 |
| GB1315439A (en) | 1973-05-02 |
| IL38096A0 (en) | 1972-01-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VJC | Lapsed due to non-payment of the due maintenance fee for the patent or patent application | ||
| NL80 | Information provided on patent owner name for an already discontinued patent |
Owner name: FARMACEUTICI |